Prostate cancer trials in Lithuania

4 of 8 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Where

  Kaunas, Vilnius

  Age

  18 years and over

  People

  1,314 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136650 · EU 2023-504957-11-00
• No phaseNot yet taking people in Lithuania
  Effects of Direct Artery Injection on Prostate Cancer Drug Delivery and Tumor Uptake: Imaging-Based Prediction of Treatment Effectiveness

  Where

  Kaunas

  Age

  18 years and over

  People

  10

  Run by

  Lithuanian University of Health Sciences

  See details and how to joinNCT07656337
• Phase 2Not yet taking people in Lithuania
  A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

  Where

  Kaunas, Klaipeda, Vilnius

  Age

  18 years to 85 years

  People

  40

  Run by

  Antev Ltd.

  See details and how to joinNCT07457164 · EU 2023-509255-14-01
• No phaseEnrolling by invitation
  Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage

  Where

  Kaunas

  Age

  18 years to 100 years

  People

  400

  Run by

  Edgaras Burzinskis

  See details and how to joinNCT06505356